2022 annual financial data
bioAffinity Technologies 2022 Revenue growth
Direct answer
Revenue growth was 267.76%.
Operating income was -4,011,058 USD and net income was -8,154,113 USD.
Operating cash flow was -4,070,845 USD.
Get free bioAffinity Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,803 USD
- Operating income
- -4,011,058 USD
- Net income
- -8,154,113 USD
- Operating cash flow
- -4,070,845 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all bioAffinity Technologies financial years